MetLife Investment Management’s Veracyte VCYT Stock Holding History

MetLife Investment Management’s Portfolio VCYT Stock Details VCYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.77M	Buy	47,149 +3,030	+7%	+$127K	0.01%	956
2026 Q1	$1.42M	Buy	44,119 +466	+1%	+$17.3K	0.01%	1235
2025 Q4	$1.84M	Sell	43,653 -2,656	-6%	-$107K	0.01%	1120
2025 Q3	$1.59M	Hold	46,309	–	–	0.01%	1214
2025 Q2	$1.25M	Sell	46,309 -83	-0.2%	-$2.4K	0.01%	1196
2025 Q1	$1.38M	Sell	46,392 -553	-1%	-$21.1K	0.01%	1219
2024 Q4	$1.86M	Buy	46,945 +3,078	+7%	+$117K	0.01%	1085
2024 Q3	$1.49M	Hold	43,867	–	–	0.01%	1174
2024 Q2	$951K	Buy	43,867 +5,338	+14%	+$112K	0.01%	1369
2024 Q1	$854K	Hold	38,529	–	–	0.01%	1387
2023 Q4	$1.06M	Hold	38,529	–	–	0.01%	1264
2023 Q3	$860K	Hold	38,529	–	–	0.01%	1313
2023 Q2	$981K	Buy	38,529 +579	+2%	+$14K	0.01%	1284
2023 Q1	$846K	Hold	37,950	–	–	0.01%	1315
2022 Q4	$901K	Hold	37,950	–	–	0.01%	1272
2022 Q3	$630K	Hold	37,950	–	–	0.01%	1468
2022 Q2	$755K	Hold	37,950	–	–	0.01%	1376
2022 Q1	$1.05M	Buy	37,950 +13,393	+55%	+$383K	0.01%	1296
2021 Q4	$1.01M	Hold	24,557	–	–	0.01%	1117
2021 Q3	$1.14M	Hold	24,557	–	–	0.01%	1066
2021 Q2	$982K	Hold	24,557	–	–	0.01%	1171
2021 Q1	$1.32M	Buy	24,557 +181	+0.7%	+$10.4K	0.01%	1006
2020 Q4	$1.19M	Hold	24,376	–	–	0.01%	1049
2020 Q3	$792K	Buy	24,376 +2,930	+14%	+$93.1K	0.01%	1146
2020 Q2	$555K	Hold	21,446	–	–	0.01%	1320
2020 Q1	$521K	Hold	21,446	–	–	0.01%	1198
2019 Q4	$599K	Hold	21,446	–	–	0.01%	1361
2019 Q3	$515K	Buy	21,446 +6,889	+47%	+$183K	0.01%	1403
2019 Q2	$415K	Sell	14,557 -29,114	-67%	-$727K	﹤0.01%	1595
2019 Q1	$1.09M	Buy	43,671 +29,114	+200%	+$556K	﹤0.01%	1608
2018 Q4	$183K	Hold	14,557	–	–	﹤0.01%	1961
2018 Q3	$139K	Buy	+14,557	New	+$161K	﹤0.01%	2285

Other funds holding VCYT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

MetLife Investment Management's VCYT Position: Q2 2026 in Review

MetLife Investment Management increased its Veracyte (VCYT) stake by 6.9% in Q2 2026, buying an estimated $127K and bringing the position to 47,149 shares worth $2.77M. The position accounts for 0.01% of the portfolio, ranked #956.

MetLife Investment Management first reported a position in VCYT in Q3 2018 and has held it in 32 quarters since. 370 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.

MetLife Investment Management held 47,149 shares of Veracyte worth $2.77M as of Q2 2026.
MetLife Investment Management bought 3,030 Veracyte shares in Q2 2026, an estimated $127K.
Veracyte made up 0.01% of MetLife Investment Management's portfolio in Q2 2026, its #956 holding.
MetLife Investment Management first reported a position in Veracyte in Q3 2018 and has held it in 32 quarters since.
370 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.

Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.